Features Screener Stocks Charts
Sign In Sign Up

ALKEM Income Statement

NSE:ALKEM | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year ALKEM income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 129.78B 134.58B
Cost of Revenue -49.38B -47.64B
Gross Profit 80.41B 86.94B
Sales, General & Admin -54.85B -56.88B
Operating Income 22.57B 26.49B
Profit Before Tax 20.23B 25.26B
Net Income 18.11B 22.15B
Diluted Shares 119.57M 119.57M
Diluted EPS 150.19 181.11

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025